NXPLNasdaqTelephone Communications (No Radiotelephone)Fiscal year ends December 31
NextPlat Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.10−0.40 (-4.22%)
Close on Oct 19, 2026
- Market cap
- $24.64M
- P/E (TTM)
- –
- Dividend yield
- –
NextPlat Corp revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Operations [Member] | $33.53M | $34.85M | $39.71M | $42.74M | $44.23M | $48.58M | $52.29M | $54.06M | $54.88M | $41.41M | $26.78M | – | 69.4% | -24.2% |
| E-Commerce [Member] | $14.76M | $14.80M | $14.61M | $14.41M | $14.54M | $13.93M | $13.79M | $12.42M | $11.52M | $10.97M | $10.98M | – | 30.6% | +1.5% |
| E-Commerce Revenue [Member] | $14.76M | $14.80M | $14.61M | $14.41M | $14.54M | $13.93M | $13.79M | – | – | – | – | – | 30.6% | +1.5% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Operations [Member] | -$2.09M | -$4.23M | -$4.60M | -$4.30M | -$9.14M | -$17.31M | -$16.76M | -$28.93M | -$24.35M | -$15.05M | -$14.66M | – | -77.2% |
| E-Commerce [Member] | -$2.45M | -$2.56M | -$4.40M | -$2.19M | -$3.42M | -$5.16M | -$6.51M | -$7.21M | -$7.26M | -$8.96M | -$8.69M | – | -28.2% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member] | $27.79M | $30.40M | $35.70M | $38.14M | $37.73M | $40.07M | $41.91M | $42.45M | $43.26M | $32.74M | $21.41M | $9.89M | 57.5% | -26.3% |
| E-Commerce Revenue [Member] | $14.76M | $14.80M | $14.61M | $14.41M | $14.54M | $13.93M | $13.79M | $12.42M | $11.52M | $10.97M | $10.98M | – | 30.6% | +1.5% |
| Service [Member] | – | – | $4.66M | $4.78M | $6.63M | $8.61M | $10.54M | $11.70M | $11.70M | $8.74M | $5.37M | $2.50M | – | – |
| Product [Member] | – | – | $49.67M | $52.97M | $52.74M | $54.50M | $55.54M | $54.78M | $54.71M | $43.63M | $32.39M | $21.25M | – | – |
| Pharmacy 340B Contract [Member] | – | – | $4.01M | $4.60M | $6.50M | $8.51M | $10.38M | $11.61M | $11.63M | $8.67M | $5.37M | $2.47M | – | – |
| E-Commerce [Member] | – | – | – | $14.41M | $14.54M | $13.93M | $13.79M | $12.42M | $11.52M | – | $10.98M | – | – | – |
| Pharmacy Prescription, Other Revenue and E-Commerce [Member] | – | – | – | – | – | – | – | – | – | – | $32.39M | – | – | – |
By region
From the segment and revenue-disaggregation notes of NextPlat's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.